Process R&D Proteometer™
The Novilytic R&D Proteometer™ is an instrument for pharmaceutical biochemists who need to develop better mAb process quality. Unlike common yet archaic monitoring technologies, the R&D Proteometer provides Artificial Intelligence solutions for production, saving $200,000/day in development costs.
The Novilytic CPV Proteometer™ is a continuous process validation instrument for pharmaceutical manufacturing professionals who need more accurate control of FDA-regulated processes. Unlike common yet archaic monitoring technologies, the CPV Proteometer utilizes AI to confirm a process deviation and suggest remediation in process.
"As analytical tools have matured for the quality control and characterization of isolated biopharmaceuticals, the application of advanced analytical systems to dynamically contribute to process monitoring and control in complex bioreactors is critical for enhanced process efficiency and product quality.
The Proteometer is expected to play a central role in the development and commercialization of next-level biological manufacturing control strategies. The integration of complementary bioprocess analytical data facilitates decision-making through a powerful link between the manufacturing space and the QC laboratory."
Eugene L. Inman, Ph.D.
Pharmaceutical Quality Consultant
Retired Eli Lilly and Company
“Novalytic’s Proteometer is a disruptive breakthrough that finally solves the FDA's requirement to continuously monitor t-mAb proteoforms during fermentation.
The approach improves product safety, reduces COPQ and post release testing, and paves the way for real-time product release, reducing inventory costs.
The solution combines novel sample handing and artificial intelligence with proven analytical technology that is easy to deploy and support, and provides near instantaneous ROI.”